AU2013207589A1 - Anti-Siglec-15 Antibody - Google Patents

Anti-Siglec-15 Antibody

Info

Publication number
AU2013207589A1
AU2013207589A1 AU2013207589A AU2013207589A AU2013207589A1 AU 2013207589 A1 AU2013207589 A1 AU 2013207589A1 AU 2013207589 A AU2013207589 A AU 2013207589A AU 2013207589 A AU2013207589 A AU 2013207589A AU 2013207589 A1 AU2013207589 A1 AU 2013207589A1
Authority
AU
Australia
Prior art keywords
siglec
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2013207589A
Other versions
AU2013207589B2 (en
Inventor
Yoshiharu Hiruma
Makiko Nakayama
Takeshi Takizawa
Eisuke Tsuda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Sankyo Co Ltd
Original Assignee
Daiichi Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2010235453A external-priority patent/AU2010235453B2/en
Application filed by Daiichi Sankyo Co Ltd filed Critical Daiichi Sankyo Co Ltd
Priority to AU2013207589A priority Critical patent/AU2013207589B2/en
Publication of AU2013207589A1 publication Critical patent/AU2013207589A1/en
Application granted granted Critical
Publication of AU2013207589B2 publication Critical patent/AU2013207589B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

AU2013207589A 2009-04-09 2013-07-17 Anti-Siglec-15 Antibody Ceased AU2013207589B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2013207589A AU2013207589B2 (en) 2009-04-09 2013-07-17 Anti-Siglec-15 Antibody

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2009-094613 2009-04-09
JP2009094613 2009-04-09
AU2010235453A AU2010235453B2 (en) 2009-04-09 2010-04-07 Anti-Siglec-15 antibody
AU2013207589A AU2013207589B2 (en) 2009-04-09 2013-07-17 Anti-Siglec-15 Antibody

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU2010235453A Division AU2010235453B2 (en) 2009-04-09 2010-04-07 Anti-Siglec-15 antibody

Publications (2)

Publication Number Publication Date
AU2013207589A1 true AU2013207589A1 (en) 2013-08-08
AU2013207589B2 AU2013207589B2 (en) 2016-04-07

Family

ID=42936292

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2010235453A Ceased AU2010235453B2 (en) 2009-04-09 2010-04-07 Anti-Siglec-15 antibody
AU2013207589A Ceased AU2013207589B2 (en) 2009-04-09 2013-07-17 Anti-Siglec-15 Antibody

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU2010235453A Ceased AU2010235453B2 (en) 2009-04-09 2010-04-07 Anti-Siglec-15 antibody

Country Status (19)

Country Link
US (3) US8575316B2 (en)
EP (2) EP2377932B1 (en)
JP (2) JP5653909B2 (en)
KR (1) KR101690340B1 (en)
CN (2) CN106317224B (en)
AU (2) AU2010235453B2 (en)
BR (1) BRPI1006134A2 (en)
CA (1) CA2750836C (en)
CO (1) CO6420359A2 (en)
ES (1) ES2840923T3 (en)
IL (2) IL213943A (en)
MX (2) MX2011007342A (en)
MY (1) MY152033A (en)
NZ (2) NZ605450A (en)
RU (2) RU2539790C2 (en)
SG (2) SG172419A1 (en)
TW (1) TWI468177B (en)
WO (1) WO2010117011A1 (en)
ZA (1) ZA201104545B (en)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8168181B2 (en) * 2006-02-13 2012-05-01 Alethia Biotherapeutics, Inc. Methods of impairing osteoclast differentiation using antibodies that bind siglec-15
US7989160B2 (en) 2006-02-13 2011-08-02 Alethia Biotherapeutics Inc. Polynucleotides and polypeptide sequences involved in the process of bone remodeling
ES2540733T3 (en) * 2007-10-11 2015-07-13 Daiichi Sankyo Company, Limited Antibody that targets Siglec-15 osteoclast-related protein
MX2011007342A (en) 2009-04-09 2011-07-21 Daiichi Sankyo Co Ltd ANTI-Siglec-15 ANTIBODY.
JP2013543382A (en) 2010-10-05 2013-12-05 第一三共株式会社 Antibodies targeting the osteoclast-related protein Siglec-15
JP6216317B2 (en) * 2011-09-09 2017-10-18 メディミューン リミテッド Anti-Siglec-15 antibody and use thereof
CA2868959A1 (en) * 2012-03-30 2013-10-03 Daiichi Sankyo Company, Limited Cdr-modified anti-siglec-15 antibody
MX2014011826A (en) * 2012-03-30 2014-11-21 Daiichi Sankyo Co Ltd Novel anti-siglec15 antibody.
EP2875051B1 (en) 2012-07-19 2019-02-20 Daiichi Sankyo Company, Limited Anti-siglec-15 antibodies
SG11201602490UA (en) 2013-09-30 2016-04-28 Daiichi Sankyo Co Ltd Anti-lps o11 antibody
US20170129956A1 (en) * 2014-06-18 2017-05-11 Daiichi Sankyo Company, Limited Anti-siglec-15 antibodies for use in treatment of osteogenesis imperfecta
US9616114B1 (en) 2014-09-18 2017-04-11 David Gordon Bermudes Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
AU2016286898B2 (en) 2015-06-29 2022-12-08 Daiichi Sankyo Company, Limited Method for selectively manufacturing antibody-drug conjugate
RU2759334C2 (en) 2016-09-21 2021-11-12 Нексткьюр, Инк. Antibodies against siglec-15 and their application methods
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
TWI782000B (en) 2017-03-30 2022-11-01 日商第一三共股份有限公司 Anti gpr20 antibodies, preparation method and application thereof
CN110913905A (en) * 2017-06-30 2020-03-24 国立大学法人北海道大学 Therapeutic agent for infantile osteoporosis without growth disturbance
JP7271424B2 (en) 2017-07-27 2023-05-11 第一三共株式会社 Anti-CD147 antibody
JP6790307B2 (en) 2018-05-31 2020-11-25 第一三共株式会社 Anti-human TLR7 antibody
KR20210040059A (en) 2018-07-27 2021-04-12 다이이찌 산쿄 가부시키가이샤 Protein Recognizing the Drug Site of an Antibody-Drug Conjugate
CN111378043B (en) * 2020-02-19 2021-02-09 南京医科大学 Human-mouse chimeric anti-Siglec-15 whole-molecule IgG with neutralization function and preparation method and application thereof
CN113817057B (en) * 2020-06-19 2024-02-20 盛禾(中国)生物制药有限公司 Anti-siglec 15 antibody and application thereof
CN112159475B (en) * 2020-10-10 2021-04-30 南京凯地生物科技有限公司 Siglec-15 monoclonal antibody and application thereof
WO2022228183A1 (en) * 2021-04-30 2022-11-03 杭州邦顺制药有限公司 Anti-siglec15 antibody, preparation method therefor and use thereof
CN113577283A (en) * 2021-07-19 2021-11-02 河北医科大学第三医院 Application of Siglec-15 inhibitor in preparation of medicines for preventing and treating giant cell tumor of bone
CN114807052A (en) * 2022-06-07 2022-07-29 江苏亲科生物研究中心有限公司 SIGLEC15 monoclonal antibody, preparation method and application thereof
WO2024040195A1 (en) 2022-08-17 2024-02-22 Capstan Therapeutics, Inc. Conditioning for in vivo immune cell engineering

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260203A (en) 1986-09-02 1993-11-09 Enzon, Inc. Single polypeptide chain binding molecules
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US5091513A (en) 1987-05-21 1992-02-25 Creative Biomolecules, Inc. Biosynthetic antibody binding sites
IL162181A (en) 1988-12-28 2006-04-10 Pdl Biopharma Inc A method of producing humanized immunoglubulin, and polynucleotides encoding the same
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
CA2109602C (en) 1990-07-10 2002-10-01 Gregory P. Winter Methods for producing members of specific binding pairs
WO1993006213A1 (en) 1991-09-23 1993-04-01 Medical Research Council Production of chimeric antibodies - a combinatorial approach
ATE275198T1 (en) 1991-12-02 2004-09-15 Medical Res Council PRODUCTION OF ANTIBODIES ON PHAGE SURFACES BASED ON ANTIBODIES SEGMENT LIBRARIES.
JP3507073B2 (en) 1992-03-24 2004-03-15 ケンブリッジ アンティボディー テクノロジー リミティド Methods for producing members of a specific binding pair
GB9313509D0 (en) 1993-06-30 1993-08-11 Medical Res Council Chemisynthetic libraries
AU690171B2 (en) 1993-12-03 1998-04-23 Medical Research Council Recombinant binding proteins and peptides
IL117175A (en) 1995-02-20 2005-11-20 Sankyo Co Osteoclastogenesis inhibitory factor protein
DE19653646A1 (en) 1996-12-20 1998-06-25 Hoechst Ag Substituted purine derivatives, processes for their preparation, agents containing them and their use
HU229476B1 (en) 1997-04-15 2014-01-28 Daiichi Sankyo Company Antibodies against obm
DK1071700T3 (en) 1998-04-20 2010-06-07 Glycart Biotechnology Ag Glycosylation modification of antibodies to enhance antibody-dependent cellular cytotoxicity
ES2420835T3 (en) 1999-04-09 2013-08-27 Kyowa Hakko Kirin Co., Ltd. Procedure to control the activity of immunofunctional molecules
BR0114475A (en) 2000-10-06 2003-12-23 Kyowa Hakko Kogyo Kk Cell for the production of antibody composition
US7608704B2 (en) 2000-11-08 2009-10-27 Incyte Corporation Secreted proteins
AU2002233994A1 (en) 2000-11-08 2002-05-21 Incyte Genomics, Inc. Secreted proteins
WO2002064771A1 (en) 2001-02-15 2002-08-22 Mochida Pharmaceutical Co., Ltd. Novel cell adhesion molecule specific to activated leukocyte
PT2087908T (en) 2001-06-26 2018-07-16 Amgen Inc Antibodies to opgl
AU2002364699A1 (en) 2001-11-13 2003-06-17 Incyte Genomics, Inc. Receptors and membrane-associated proteins
US7193069B2 (en) 2002-03-22 2007-03-20 Research Association For Biotechnology Full-length cDNA
EP1494714A4 (en) 2002-04-05 2008-03-05 Amgen Inc Human anti-opgl neutralizing antibodies as selective opgl pathway inhibitors
DE602004002275T2 (en) 2003-01-07 2007-09-06 Symphogen A/S PROCESS FOR PRODUCING RECOMBINANT POLYCLONAL PROTEINS
TWI359026B (en) 2004-02-12 2012-03-01 Sankyo Co Pharmaceutical composition for the osteoclast rela
US7405037B2 (en) 2004-05-07 2008-07-29 Lonza Walkersville, Inc. Methods and tools for detecting collagen degradation
JP4604184B2 (en) * 2005-07-12 2010-12-22 独立行政法人産業技術総合研究所 Novel sugar chain recognition protein and its gene
US7989160B2 (en) 2006-02-13 2011-08-02 Alethia Biotherapeutics Inc. Polynucleotides and polypeptide sequences involved in the process of bone remodeling
US8168181B2 (en) 2006-02-13 2012-05-01 Alethia Biotherapeutics, Inc. Methods of impairing osteoclast differentiation using antibodies that bind siglec-15
ES2540733T3 (en) 2007-10-11 2015-07-13 Daiichi Sankyo Company, Limited Antibody that targets Siglec-15 osteoclast-related protein
MX2011007342A (en) 2009-04-09 2011-07-21 Daiichi Sankyo Co Ltd ANTI-Siglec-15 ANTIBODY.

Similar Documents

Publication Publication Date Title
AU2013207589A1 (en) Anti-Siglec-15 Antibody
ZA201104545B (en) Anti-siglec-15 antibody
EP3514173B8 (en) Dkk-1 antibodies
GB2473934B (en) Anti-VEEV antibody
AU2009100824A4 (en) Heslr
AU2009100437A4 (en) Pippetop
AU2009100982A4 (en) Flip - barbi
AU2009100147A4 (en) Safetank
AU2009100564A4 (en) Agwave
AU2009100680A4 (en) Ezy-Lay
AU2009100423A4 (en) Byak
AU2009100848A4 (en) Headbags
AU2009100472A4 (en) Duramind
AU2009100549A4 (en) XBlend
AU2009100092A4 (en) Interfilm
AU2009101028A4 (en) Hybridtelerent
AU2009101120A4 (en) Koolkilt
AU2009902142A0 (en) Variant domain antibodies
GB0911712D0 (en) Antibody
AU2009901647A0 (en) Pumpbox
AU2009901036A0 (en) e-AD
AU2009901509A0 (en) Scoods
AU2009901345A0 (en) Camsok
AU2009901319A0 (en) Caralift
AU2009901300A0 (en) Thermomoulding